Nurofen Express Lady tab.po.400mg No.12


Contraindications

The product is not used for the following conditions and diseases:

  • increased sensitivity of the body to ibuprofen or other components of the drug;
  • history of high sensitivity to NSAIDs;
  • exacerbation of erosive and ulcerative diseases of the gastrointestinal tract, ulcerative bleeding in the acute stage or in history;
  • serious kidney disease, liver failure, severe renal failure
  • confirmed hyperkalemia;
  • severe heart failure;
  • hemophilia bleeding disorders ;
  • intracranial hemorrhages;
  • recovery period after coronary artery bypass surgery;
  • glucose-galactose malabsorption, fructose intolerance, sucrase-isomaltase deficiency;
  • third trimester of pregnancy ;
  • child's age up to 12 years.

Nurofen Lady is prescribed with caution for allergic diseases, bronchial asthma during exacerbation, systemic lupus erythematosus , elderly people, peripheral arterial diseases, coronary artery disease, diabetes , liver cirrhosis , gastritis , hyperbilirubinemia , severe somatic diseases .

The drug is also carefully prescribed to patients who smoke and often drink alcohol.

Nurofen Express Lady tab.po.400mg No.12

Indications

Symptomatic treatment as an anti-inflammatory and antipyretic agent: inflammatory and degenerative diseases of the joints and spine (including rheumatic and rheumatoid arthritis, ankylosing spondylitis, osteoarthritis), articular syndrome with exacerbation of gout, psoriatic arthritis, ankylosing spondylitis, tendinitis, bursitis, radiculitis , traumatic inflammation of soft tissues and the musculoskeletal system. Neuralgia, myalgia, pain syndrome due to infectious and inflammatory diseases of the ENT organs, adnexitis, algodismenorrhea, headache and toothache. Fever in infectious and inflammatory diseases, childhood infections, post-vaccination reactions in children (in appropriate dosage forms).

pharmachologic effect

NSAIDs, a derivative of phenylpropionic acid. It has anti-inflammatory, analgesic and antipyretic effects.

The mechanism of action is associated with inhibition of the activity of COX, the main enzyme in the metabolism of arachidonic acid, which is a precursor of prostaglandins, which play a major role in the pathogenesis of inflammation, pain and fever. The analgesic effect is due to both peripheral (indirectly, through suppression of prostaglandin synthesis) and central mechanisms (inhibition of prostaglandin synthesis in the central and peripheral nervous system). Suppresses platelet aggregation.

Drug interactions

With simultaneous use, ibuprofen reduces the effect of antihypertensive drugs (ACE inhibitors, beta-blockers), diuretics (furosemide, hydrochlorothiazide).

When used simultaneously with anticoagulants, their effect may be enhanced.

When used simultaneously with GCS, the risk of side effects from the gastrointestinal tract increases.

When used simultaneously, ibuprofen can displace indirect anticoagulants (acenocoumarol), hydantoin derivatives (phenytoin), and oral hypoglycemic drugs, sulfonylurea derivatives, from compounds with blood plasma proteins.

When used simultaneously with amlodipine, a slight decrease in the antihypertensive effect of amlodipine is possible; with acetylsalicylic acid - the concentration of ibuprofen in the blood plasma decreases; with baclofen - a case of increased toxic effects of baclofen has been described.

When used simultaneously with warfarin, an increase in bleeding time is possible; microhematuria and hematomas were also observed; with captopril - the antihypertensive effect of captopril may be reduced; with cholestyramine - a moderate decrease in the absorption of ibuprofen.

When used simultaneously with lithium carbonate, the concentration of lithium in the blood plasma increases.

When used simultaneously with magnesium hydroxide, the initial absorption of ibuprofen increases; with methotrexate - the toxicity of methotrexate increases.

The simultaneous use of NSAIDs and cardiac glycosides can lead to worsening heart failure, a decrease in glomerular filtration rate and an increase in the concentration of cardiac glycosides in the blood plasma.

There is evidence of the likelihood of an increase in the concentration of methotrexate in the blood plasma during the use of NSAIDs.

With simultaneous use of NSAIDs and cyclosporine, the risk of nephrotoxicity increases.

NSAIDs may reduce the effectiveness of mifepristone, so taking NSAIDs should be started no earlier than 8-12 days after stopping mifepristone.

Concomitant use of NSAIDs and tacrolimus may increase the risk of nephrotoxicity.

Concomitant use of NSAIDs and zidovudine may lead to increased hematotoxicity. There is evidence of an increased risk of hemarthrosis and hematomas in HIV-positive patients with hemophilia who received concomitant treatment with zidovudine and ibuprofen.

In patients receiving concomitant treatment with NSAIDs and quinolone antibiotics, the risk of seizures may increase.

In patients receiving concomitant NSAIDs and myelotoxic drugs, hematotoxicity increases.

With the simultaneous use of ibuprofen and cefamandole, cefoperazone, cefotetan, valproic acid, plicamycin, the incidence of hypoprothrombinemia increases.

With the simultaneous use of ibuprofen and drugs that block tubular secretion, there is a decrease in excretion and an increase in plasma concentration of ibuprofen.

With the simultaneous use of ibuprofen and inducers of microsomal oxidation (phenytoin, ethanol, barbiturates, rifampicin, phenylbutazone, tricyclic antidepressants), there is an increase in the production of hydroxylated active metabolites and an increased risk of developing severe intoxications.

Dosage regimen

Taken orally. The individual dosage regimen depends on the indications, the severity of clinical manifestations, and the patient’s age.

A single dose for adults and children over 6 years of age is 200-400 mg. Can be taken 3-4 times a day.

The maximum daily dose for adults is 1200 mg; for children aged 12-17 years - 1000 mg; for children aged 6 to 12 years - 800 mg.

For children under 6 years of age, the dose depends on the age and body weight of the child. The maximum daily dose should not exceed 30 mg/kg body weight with intervals between doses of the drug of 6-8 hours.

AgeBody massDosage regimenMaximum daily dose
3-6 months5kg-7.6kg50 mg up to 3 times/day150 mg
6-12 months7.7-9 kg50 mg up to 3-4 times/day200 mg
1-3 years10-16 kg100 mg up to 3 times/day300 mg
4-6 years17-20 kg150 mg up to 3 times a day450 mg

Contraindications for use

Hypersensitivity to ibuprofen; erosive and ulcerative lesions of the gastrointestinal tract in the acute phase or ulcerative bleeding in the active phase or in history (2 or more confirmed episodes of peptic ulcer disease or ulcerative bleeding); a history of bleeding or perforation of a gastrointestinal ulcer caused by the use of NSAIDs; severe heart failure (functional class IV according to the NYHA classification); severe renal and/or liver dysfunction; diseases of the optic nerve, “aspirin triad”, hematopoietic disorders; period after coronary artery bypass surgery; intracranial or other bleeding; hemophilia and other bleeding disorders (including hypocoagulation), hemorrhagic diathesis; III trimester of pregnancy.

With caution: simultaneous use of other NSAIDs; a history of a single episode of gastric and duodenal ulcers or ulcerative bleeding of the gastrointestinal tract; gastritis, enteritis, colitis, the presence of Helicobacter pylori infection, ulcerative colitis; bronchial asthma or allergic diseases in the acute stage or in history; systemic lupus erythematosus or mixed connective tissue disease (Sharpe's syndrome) - increased risk of aseptic meningitis; chicken pox; renal failure, incl. with dehydration (creatinine clearance less than 30-60 ml/min), nephrotic syndrome, liver failure, liver cirrhosis with portal hypertension; hyperbilirubinemia; arterial hypertension and/or heart failure; cerebrovascular diseases; blood diseases of unknown etiology (leukopenia and anemia); severe somatic diseases; dyslipidemia/hyperlipidemia; diabetes; peripheral arterial disease; smoking; frequent drinking of alcohol; simultaneous use of drugs that may increase the risk of ulcers or bleeding, in particular, oral corticosteroids (including prednisolone), anticoagulants (including warfarin), selective serotonin reuptake inhibitors (including citalopram , fluoxetine, paroxetine, sertratine) or antiplatelet agents (including acetylsalicylic acid, clopidogrel); I-II trimester of pregnancy; breastfeeding period; elderly age.

Use in children

Can be used according to indications in recommended doses.

Restrictions for children

Possible use

Use in elderly patients

Caution should be used in elderly patients to avoid worsening the course of concomitant diseases.

In elderly patients, there is an increased incidence of adverse reactions due to the use of NSAIDs, especially gastrointestinal bleeding and perforation, in some cases with a fatal outcome.

Restrictions for elderly patients

Use with caution

Use for liver dysfunction

Contraindicated in cases of severe liver dysfunction. Use with caution in case of concomitant liver diseases.

Restrictions for liver dysfunction

Use with caution

Use during pregnancy and breastfeeding

Use during pregnancy and breastfeeding is contraindicated.

Restrictions when breastfeeding

Contraindicated

Restrictions during pregnancy

Contraindicated

Use for renal impairment

Contraindicated in cases of severe renal impairment. Use with caution in case of concomitant kidney diseases.

Restrictions for impaired renal function

Use with caution

special instructions

It is recommended to prescribe ibuprofen for the shortest possible course and at the minimum effective dose necessary to eliminate symptoms. If systemic use is necessary for more than 10 days, you should consult your doctor.

During long-term treatment, monitoring of the peripheral blood picture and the functional state of the liver and kidneys is necessary. When symptoms of gastropathy appear, careful monitoring is indicated, including esophagogastroduodenoscopy, a complete blood count (hemoglobin determination), and a stool test for occult blood.

The use of NSAIDs in patients with chickenpox may be associated with an increased risk of developing severe purulent complications of infectious and inflammatory diseases of the skin and subcutaneous fat (for example, necrotizing fasciitis). Therefore, it is recommended to avoid the use of ibuprofen for chickenpox.

Ibuprofen suppresses COX and prostaglandin synthesis, affects ovulation, disrupting female reproductive function (reversible after discontinuation of treatment).

Impact on the ability to drive vehicles and machinery

Patients who experience dizziness, drowsiness, lethargy, or blurred vision while taking ibuprofen should avoid driving and other activities that require high concentration and speed of psychomotor reactions.

Side effect

From the hematopoietic system: very rarely - hematopoietic disorders (anemia, leukopenia, aplastic anemia, hemolytic anemia, thrombocytopenia, pancytopenia, agranulocytosis).

From the immune system: infrequently - hypersensitivity reactions - nonspecific allergic reactions and anaphylactic reactions, reactions from the respiratory tract (bronchial asthma, including its exacerbation, bronchospasm, shortness of breath, dyspnea), skin reactions (itching, urticaria, purpura, Quincke's edema, exfoliative and bullous dermatoses, including toxic epidermal necrolysis (Lyell's syndrome), Stevens-Johnson syndrome, erythema multiforme), allergic rhinitis, eosinophilia; very rarely - severe hypersensitivity reactions, incl. swelling of the face, tongue and larynx, shortness of breath, tachycardia, arterial hypotension (anaphylaxis, Quincke's edema or severe anaphylactic shock).

From the digestive system: infrequently - abdominal pain, nausea, dyspepsia (including heartburn, bloating); rarely - diarrhea, flatulence, constipation, vomiting; very rarely - peptic ulcer, perforation or gastrointestinal bleeding, melena, hematemesis, in some cases fatal, especially in elderly patients, ulcerative stomatitis, gastritis; frequency unknown - exacerbation of colitis and Crohn's disease.

From the liver and biliary tract: very rarely - liver dysfunction, increased activity of liver transaminases, hepatitis and jaundice.

From the urinary system: very rarely - acute renal failure (compensated and decompensated), especially with long-term use, in combination with an increase in the concentration of urea in the blood plasma and the appearance of edema, hematuria and proteinuria; nephritic syndrome, nephrotic syndrome, papillary necrosis, interstitial nephritis, cystitis.

From the nervous system: infrequently - headache; very rarely - aseptic meningitis.

From the cardiovascular system: frequency unknown - heart failure, peripheral edema; with long-term use, the risk of thrombotic complications (for example, myocardial infarction, stroke) and increased blood pressure are increased.

From the respiratory system: frequency unknown - bronchial asthma; bronchospasm; dyspnea.

From the laboratory parameters: possible - decrease in hematocrit or hemoglobin, increase in bleeding time, decrease in the concentration of glucose in the blood plasma, decrease in creatinine clearance, increase in the concentration of creatinine in the blood plasma, increase in the activity of liver transaminases.

Possible product names

  • Nurofen Express Lady tab.po.400mg No.12
  • NUROFEN EXPRESS LADY 400 MG TAB. P/OB. No. 12
  • NUROFEN EXPRESS LADY 0.4 N12 TABLE P/O
  • NUROFEN EXPRESS LADY TAB. P/O 400MG No. 12
  • (Nurofen express) Nurofen Express Lady tab.p.o.400mg No. 12

Side effects

The likelihood of developing side effects can be minimized if the patient takes the drug for a short period of time and does not exceed the recommended dosage. Please note that the incidence of side effects is higher in older people. With short-term use of the drug, the following side effects were observed:

  • lymphatic system, blood: hematopoietic disorders;
  • immune system: increased sensitivity, resulting in the development of urticaria and itching , in rare cases - bronchospasm, exacerbation of bronchial asthma, severe hypersensitivity reactions;
  • gastrointestinal tract: nausea, gastritis , bloating, abdominal pain, dyspepsia, flatulence , diarrhea , constipation ;
  • urinary system, liver: in rare cases - liver dysfunction, hepatitis , jaundice , interstitial nephritis , renal failure, papillonecrosis ;
  • nervous system : headache, dizziness , in rare cases - stroke , aseptic meningitis , nervousness ;
  • sense organs: in rare cases - ringing in the ears, blurred vision;
  • cardiovascular system: in rare cases - hypertension , heart failure ;
  • respiratory system: bronchospasm , bronchial asthma , shortness of breath , wheezing ;
  • skin: rash, in rare cases - toxic epidermal necrolysis , severe skin reactions;
  • changes in laboratory parameters.

Nurofen Express lady

Nurofen Express Lady (INN - ibuprofen) is an NSAID, a derivative of propionic acid. The mechanism of action is associated with suppression of the production of nociceptive and proinflammatory neurotransmitters prostaglandins. Non-selectively inactivates the enzyme cyclooxygenase types 1 and 2, as a result of which the production of prostaglandins is blocked. Exhibits rapid and accentuated analgesic, anti-inflammatory and antipyretic effects. Reversibly inhibits the ability of platelets to form aggregations (stick together). It is quickly and completely absorbed from the gastrointestinal tract. When taken on an empty stomach, peak concentration in the blood is observed after 30-35 minutes. The presence of food contents in the gastrointestinal tract can increase the time it takes to reach the peak concentration of the active substance in the blood. Subject to metabolic transformations in the liver. The half-life is approximately 2 hours. Elimination from the body occurs mainly through urine and, to a small extent, through bile. Prescribed for cephalgia (including migraine headaches), dentalgia, algomenorrhea, peripheral nerve lesions characterized by attacks of pain in the area of ​​innervation of any nerve, spinal pain, arthralgia, myalgia, pain of rheumatic origin, febrile body temperature with influenza and influenza-like conditions. Intended for short-term use only. Single dose – 1 tablet. Frequency of administration – up to 3 times a day with an interval of at least 4 hours. If, when using the drug for 2-3 days, the clinical picture does not change or an increase in symptoms is noted, pharmacotherapy should be interrupted and medical advice should be sought. Use of the drug for more than 10 days requires consultation with a doctor. The likelihood of unwanted side effects remains minimal when using the drug for 2-3 days at the smallest dose necessary to relieve symptoms. Elderly patients have an increased risk of side effects from NSAID drugs, primarily bleeding into the lumen of the stomach and intestines and perforations.

The likelihood of development and severity of side effects largely depend on the dose taken. Typical side effects of the drug: allergic manifestations (bronchial spasm, rhinitis, shortness of breath), epigastric pain, painful sensation in the epigastric region, chest, oral cavity and pharynx, preceding vomiting, frequent bowel movements with watery stools, increased gas formation, burning sensation in the esophagus, cephalgia, a sensation of painful tickling irritation of the skin, causing the need to scratch the irritated area, urticaria. The drug is not prescribed for individual intolerance to the active or any auxiliary component, ulcerative-erosive lesions of the digestive tract, severe renal and/or liver failure, decompensated myocardial dysfunction, from the 28th week of pregnancy and immediately until the birth of the child. In pediatric practice, the drug is used after the patient reaches 12 years of age. In case of prolonged use of the drug, it is necessary to monitor biochemical parameters of peripheral blood, functional parameters of the liver and kidneys. If signs of drug-induced gastropathy appear, strict medical monitoring of the patient’s condition should be organized, including esophagogastroduodenoscopy, general and biochemical blood tests, and stool testing for occult blood. The use of the drug is not compatible with the consumption of ethanol-containing products. Persons suffering from arterial hypertension should consult a doctor before using the drug, because ibuprofen can provoke the development of edema and increased blood pressure. It is not recommended to take the drug together with acetylsalicylic acid (except when the latter is used in low doses).

Interaction

You should not take Nurofen Lady Express at the same time as the following medications:

  • with A spirin , as the risk of side effects increases. Ibuprofen reduces the antiplatelet and anti-inflammatory effect of acetylsalicylic acid;
  • with other NSAIDs : the simultaneous use of two or more drugs that belong to the NSAID group should be avoided, as the risk of side effects increases;
  • with anticoagulants : their effect is enhanced when taken together with NSAIDs;
  • with antihypertensive drugs (ACE inhibitors and angiotensin II antagonists) and diuretics - ibuprofen reduces their effectiveness, in turn, these drugs increase the nephrotoxicity of NSAIDs;
  • with antiplatelet agents and selective serotonin reuptake inhibitors , as the likelihood of bleeding from the gastrointestinal tract increases;
  • with corticosteroids , as the risk of bleeding from the gastrointestinal tract and the formation of ulcers increases;
  • with lithium preparations due to the possibility of increasing the concentration of lithium in the blood ;
  • with cardiac glycosides , the simultaneous administration of which with ibuprofen can lead to worsening heart failure and deterioration of other indicators;
  • with Methotrexate , the concentration of which may increase while taking NSAIDs;
  • with Cyclosporine , tacrolimus due to an increased likelihood of nephrotoxicity;
  • with Mifepristone , since NSAIDs reduce the effectiveness of mifepristone;
  • with Zidovudine , since concomitant use may increase hematotoxicity ;
  • with quinolone antibiotics , since there is a possibility of seizures;
  • with myelotoxic drugs due to increased hematotoxicity .

Analogs

Level 4 ATC code matches:
Artrum

Brustan

Ketonal Duo

Nurofen Plus

Nurofen Express

Nurofen Forte

Nurofen for children

Nurofen

Ibuprom

Ibuprofen

Advil

MIG 400

Has

Ketoprofen

Vimovo

Naproxen

Flexen

Nalgesin

Flamax

Novigan

Analogues of this drug are a number of drugs whose active ingredient is ibuprofen . These drugs are Advil , Ibuprom , Ibuprofen , Faspik , etc.

Rating
( 1 rating, average 5 out of 5 )
Did you like the article? Share with friends:
For any suggestions regarding the site: [email protected]
Для любых предложений по сайту: [email protected]